Wellmend Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Haveli, Maharashtra, India, established in 2024.
2024 Haveli, Maharashtra, India Active
Last Updated:
Access Report
About Wellmend Pharmaceutical Private Limited

Wellmend Pharmaceutical Private Limited, a active private limited company, was established on 20 June 2024 in Haveli, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U21000PN2024PTC231960. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Anil Popatrao Belkar (Director), Soham Sandeep Parakh (Director), Sandeep Sampatlal Parakh (Director). It is based at C/O Atul Ashok Kad,, Gat No 1257 Khoke Nagar,H, Haveli, Maharashtra, 412308.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21000PN2024PTC231960

  • Registration Number

    231960

  • Incorporation Date

    20 June 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 7 Months
Company report

Wellmend Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Wellmend Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Wellmend Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Anil Popatrao Belkar Director 20 Jun 2024 Current
Soham Sandeep Parakh Director 20 Jun 2024 Current
Sandeep Sampatlal Parakh Director 20 Jun 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wellmend Pharmaceutical.

Enhance accessibility to Wellmend Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Wellmend Pharmaceutical revenue growth over time
Wellmend Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wellmend Pharmaceutical?

Unlock access to Wellmend Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Wellmend Pharmaceutical?

Unlock and access historical data on people associated with Wellmend Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wellmend Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellmend Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wellmend Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    The activity Anil Popatrao Belkar was appointed as a Director was appointed as a Director on 20 Jun 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Director Appointment

    Progress on Soham Sandeep Parakh was appointed as a Director was appointed as a Director on 20 Jun 2024 & has been associated with this company since 1 year 7 months . was documented.

  • Director Appointment

    Progress on Sandeep Sampatlal Parakh was appointed as a Director was appointed as a Director on 20 Jun 2024 & has been associated with this company since 1 year 7 months . was documented.

  • Company Incorporation

    Wellmend Pharmaceutical Private Limited was registered on 20 Jun 2024 with Roc Pune & aged 1 year 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wellmend Pharmaceutical Private Limited?

The CIN of Wellmend Pharmaceutical Private Limited is U21000PN2024PTC231960.

Where is Wellmend Pharmaceutical Private Limited headquartered?

Wellmend Pharmaceutical Private Limited is headquartered at C/O Atul Ashok Kad,, Gat No 1257 Khoke Nagar,H, Haveli, Maharashtra, 412308.

When was Wellmend Pharmaceutical Private Limited incorporated?

Wellmend Pharmaceutical Private Limited was incorporated on 20 June 2024.

Who are the current directors of Wellmend Pharmaceutical Private Limited?

The current directors of Wellmend Pharmaceutical Private Limited are

What is the primary industry of Wellmend Pharmaceutical Private Limited?

The primary industry of Wellmend Pharmaceutical Private Limited is Pharma.

Is Wellmend Pharmaceutical Private Limited a listed company?

Wellmend Pharmaceutical Private Limited is unlisted.

What is the capital structure of Wellmend Pharmaceutical Private Limited?

The authorized capital of Wellmend Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available